Future Science Group
Suppl. 1475.pdf (1.07 MB)

Supplementary Figures – Turalio Risk Evaluation and Mitigation Strategy for treatment of tenosynovial giant cell tumor: framework and experience

Download (1.07 MB)
posted on 2022-02-03, 10:57 authored by Figshare Future Science GroupFigshare Future Science Group, Charles Dharmani, Eric Wang, Maribel Salas, Colleen McCabe, Alvileen Diggs, Youngsook Choi, Jason Jiang, Vicki L. Keedy

Supplemental Figure 1. Modified FDA framework for benefit-risk counseling to patients about drugs with a REMS* [1]

Supplementary Figure 2. Turalio® REMS Patient Enrollment Form [2]

Supplementary Figure 3. Turalio® REMS Prescriber Enrollment Form [3]

Supplementary Figure 4. Turalio® REMS Liver Adverse Event Reporting Form [4]

Supplemental Figure 5. Turalio® REMS Pharmacy Enrollment Form [5]

Supplemental Figure 6. Turalio REMS framework


Daiichi Sankyo, Inc.